Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
94 hedge funds and large institutions have $639M invested in Epizyme, Inc in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 10 closing their positions.
1,498% more call options, than puts
Call options by funds: $783K | Put options by funds: $49K
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
13% more funds holding
Funds holding: 83 → 94 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 29
9% less capital invested
Capital invested by funds: $699M → $639M (-$60.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$16.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.3M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$12.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.56M |
| 5 |
PA
Perceptive Advisors
New York
|
+$7.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$40.3M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$12.7M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.58M |
| 4 |
Axa
Paris,
France
|
-$2.27M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.96M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ARC
101
Absolute Return Capital
Boston,
Massachusetts
| – | -$128K | -4,108 | Closed |
|
|
VFA
102
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$34K | -1,092 | Closed |
|
103
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$5K | -160 | Closed |
|
EPZM Hedge Fund Activity: Q3 2014 in Review
94 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2014, worth a combined $639M — down 8.6% from $699M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new EPZM positions and 10 closed out — a net gain of 11 holders — while 29 added to existing stakes and 29 trimmed.
The largest buyer was State Street, adding an estimated $16.8M. The largest seller was NEA Management Company, cutting an estimated $40.3M.
- 94 institutional investors held Epizyme, Inc (EPZM) as of Q3 2014, up from 83 in Q2 2014.
- Funds reported $639M of Epizyme, Inc stock for Q3 2014, down 8.6% quarter-over-quarter.
- 21 funds opened new Epizyme, Inc positions in Q3 2014 and 10 closed out, a net change of +11 holders.
- The largest Epizyme, Inc buyer in Q3 2014 was State Street, an estimated $16.8M added.
- The largest Epizyme, Inc seller in Q3 2014 was NEA Management Company, an estimated $40.3M sold.
Based on aggregated 13F filings for Q3 2014.